Login / Signup
Xueqiang Tao
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Endometrial Cancer
Poor Prognosis
Tyrosine Kinase
Epidermal Growth Factor Receptor
Top Venues
Journal of gynecologic oncology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Fen Xue
,
Lifen Liu
,
Xueqiang Tao
,
Weipei Zhu
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway.
Journal of gynecologic oncology
(2024)